SI1908461T1
Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
63 members in 27 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 0301849 | France | A | |
| 0301849 | France | A | |
| 45357403 | United States of America | A | |
| 45357403 | United States of America | A | |
| 07123564 | European Patent Office (EPO) | A | |
| 07123564 | European Patent Office (EPO) | A | |
| 0301849 | – | – | – |
| 071235642 | – | – | – |
| 453574 | – | – | – |
| EP20070123564 | – | – | – |
| FR20030001849 | – | – | – |
| US20030453574 | – | – | – |
Members63
| Document | Office | Kind | |
|---|---|---|---|
| US2004162334A1 | United States of America | A1 | |
| FR2851163A1 | France | A1 | |
| AU2004216452A1 | Australia | A1 | |
| CA2514948A1 | Canada | A1 | |
| WO2004075886A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2004259953A1 | United States of America | A1 | |
| NO20054228L | Norway | L | |
| KR20050096190A | Republic of Korea | A | |
| MXPA05008652A | Mexico | A | |
| MA27655A1 | Morocco | A1 | |
| EP1601349A1 | European Patent Office (EPO) | A1 | |
| US2006014837A1 | United States of America | A1 | |
| RU2005128548A | Russian Federation | A | |
| BRPI0407256A | Brazil | A | |
| PL378057A1 | Poland | A1 | |
| US7005452B2 | United States of America | B2 | |
| CN1750817A | China | A | |
| HK1079117A1 | Hong Kong, China | A1 | |
| ZA200506566B | South Africa | B | |
| US7074833B2 | United States of America | B2 | |
| JP2006517571A | Japan | A | |
| FR2851163B1 | France | B1 | |
| TNSN05195A1 | Tunisia | A1 | |
| RU2317817C2 | Russian Federation | C2 | |
| EP1908461A1 | European Patent Office (EPO) | A1 | |
| EP1601349B1 | European Patent Office (EPO) | B1 | |
| AT401872T | Austria | T | |
| ATE401872T1 | Austria | T1 | |
| DE602004015257D1 | Germany | D1 | |
| AU2004216452B2 | Australia | B2 | |
| DK1601349T3 | Denmark | T3 | |
| PT1601349E | Portugal | E | |
| SI1601349T1 | Slovenia | T1 | |
| UA84697C2 | Ukraine | C2 | |
| HK1115329A | Hong Kong, China | A | |
| HK1115329A1 | Hong Kong, China | A1 | |
| ES2310715T3 | Spain | T3 | |
| NZ541733A | New Zealand | A | |
| JP2010090143A | Japan | A | |
| IL170117A | Israel | A | |
| IL201038A0 | Israel | A0 | |
| IL201038D0 | Israel | D0 | |
| JP4515446B2 | Japan | B2 | |
| NZ575218A | New Zealand | A | |
| CN1750817B | China | B | |
| EP1908461B1 | European Patent Office (EPO) | B1 | |
| EP2305225A1 | European Patent Office (EPO) | A1 | |
| AT501716T | Austria | T | |
| ATE501716T1 | Austria | T1 | |
| DE602004031893D1 | Germany | D1 | |
| SI1908461T1This record | Slovenia | T1 | |
| DK1908461T3 | Denmark | T3 | |
| ES2359441T3 | Spain | T3 | |
| PT1908461E | Portugal | E | |
| EP1908461B9 | European Patent Office (EPO) | B9 | |
| KR101185322B1 | Republic of Korea | B1 | |
| USRE43879E | United States of America | E | |
| CA2514948C | Canada | C | |
| PL402987A1 | Poland | A1 | |
| NO333987B1 | Norway | B1 | |
| JP5431136B2 | Japan | B2 | |
| IL201038A | Israel | A | |
| PL219671B1 | Poland | B1 |
Numbers
- Publication, DOCDB
- 1908461
- Publication, EPODOC
- SI1908461T
- Application
- 31628
- Application, DOCDB
- 200431628
- Application, EPODOC
- SI20040031628T
Titles2
- English
- Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine
- Slovenian
- Uporaba enantiomera (1S, 2R) milnaciprana za pripravo zdravila
Classification
- CPC, 26
- A61K31/135
- A61K31/165
- A61K31/167
- A61K31/195
- A61K31/4015
- A61P1/04
- A61P13/02
- A61P13/10
- A61P21/00
- A61P25/00
- A61P25/04
- A61P25/06
- A61P25/14
- A61P25/16
- A61P25/18
- A61P25/22
- A61P25/24
- A61P25/28
- A61P25/32
- A61P25/34
- A61P25/36
- A61P3/04
- A61P37/04
- A61P43/00
- A61P9/00
- A61P9/12
- IPC, 7
- A61K31 165
- A61K31 135
- A61K31 167
- A61K31 195
- A61K31 4015
- A61P9 00
- A61P25 00